Cupid Limited announced that its equity shares have been reclassified from BSE Group B to BSE Group A by the Bombay Stock Exchange (BSE) pursuant to the Exchange's periodic review of listed companies. The reclassification, effective as of the intimation on July 11, 2026, marks a significant milestone in the company's journey as a listed enterprise. This development is expected to provide enhanced visibility among domestic and international market participants and improved accessibility for institutional investors.

The inclusion in BSE Group A signifies that the company satisfies the Exchange's prescribed eligibility criteria, representing one of the principal categories of listed securities. This transition reinforces the company's continued focus on governance, transparency, and regulatory compliance while maintaining trading under the normal rolling settlement mechanism.

Significance of the Reclassification

The shift to Group A is anticipated to offer several strategic advantages to Cupid Limited. These include a broader reach within the investment community and support for efficient price discovery and market liquidity. The company stated that this recognition reflects its disciplined business execution and operational standards.

Business Expansion and Global Reach

Cupid Limited has strengthened its position through strategic diversification and global expansion. The company exports products to more than 125 countries and holds the distinction of being the first in the world to attain WHO / UNFPA pre-qualification for both male and female condoms. Its product portfolio includes male and female condoms, water-based lubricants, IVD kits, and a range of Fast-Moving Consumer Goods (FMCG) such as fragrances and personal care items.

Key Operational Metrics

In March 2024, the company completed a strategic land acquisition in Palava, Maharashtra, to amplify production capacity. Cupid Limited has established long-term agreements with WHO / UNFPA & PFSCM, securing a substantial portion of its revenue from international markets.

Cupid Limited is on track to deliver revenue exceeding ₹150 Cr in the first quarter of FY27, marking one of the strongest quarterly performances in the Company's history. Driven by this exceptional start to the financial year and improved visibility across international and domestic markets, the management has revised its FY27 revenue outlook upward by a minimum of 10%. The revised guidance targets ₹660+ Cr, up from the previous estimate of ₹600 Cr.

Revised Revenue Outlook

The updated financial projections reflect growing confidence in the Company's diversified business model, expanding global opportunity pipeline, and increasing operating scale across multiple business verticals.

Key Growth Drivers

The revised FY27 revenue outlook is supported by multiple long-term growth drivers, including expanding opportunities across international B2B healthcare markets. This is driven by rising demand from institutional buyers, private sector customers, and government procurement programmes. The Company has successfully commenced its long-term supply agreement with Partnership for Supply Chain Management (PFSCM), Netherlands, strengthening its position in global healthcare procurement.

Strong order visibility exists across private markets, institutional business, and international tenders spanning multiple geographies. Continued growth in the Male Condom (MC) and Female Condom (FC) businesses is supported by enhanced manufacturing capabilities, customer acquisition, and wider market reach over the past twelve months. Additionally, growing opportunities in the lubricant portfolio are backed by increasing acceptance across both institutional and consumer channels.

Future Prospects

Management sees significant long-term potential in the consumer business as the Company continues to build a mainstream personal care and wellness brand. Its presence is expanding across modern trade, organised retail, and pharmacy networks across Bharat. Ongoing capacity expansion, operational efficiencies, and backward integration initiatives are expected to support sustained growth while improving profitability. The Company is also actively participating in IVD kits and menstrual cup tenders across multiple states.

Aditya Kumar Halwasiya, Chairman & Managing Director, Cupid Limited, highlighted that the strong start to FY27 reflects the transformation the Company has undergone. He noted that the strategic relationship with PFSCM has commenced on an encouraging note. Furthermore, the Company plans to operationalise its new Palava manufacturing facility in the coming quarter to further strengthen production capabilities. Management expects profit margins to remain strong, supported by favourable USD-INR realisations and an overall upward trend in pricing.